Prostate cancer (PC) is one of the most common tumors and a leading cause of mortality
among men, resulting in~ 375 000 deaths annually worldwide. Various analytical methods …

Recent years have shown that the diagnosis and monitoring of biomarkers involved in
inflammatory-associated medical conditions such as cancer, neurological disorders, viral …

Vascular endothelial growth factor (VEGF) is a key regulator of vascular formation and a
predominant protein biomarker in cancer angiogenesis. Owing to its crucial roles in the …

Since aptamers were first reported in the early 2000s, research on their use for the detection
of health-relevant analytical targets has exploded. This review article provides a brief …

According to the latest statistics, cancer is expected to account for nearly 1800000 new
cases and about 607000 deaths in the US in 2019. Approximately 40% of people with …

A porphyrin-based covalent organic framework (denoted as p-COF) was synthesized by a
simple oil-bath method and exploited as a novel sensing layer for immobilizing epidermal …

Aptamers are oligonucleotides or peptides that are selected from a pool of random
sequences that exhibit high affinity toward a specific biomolecular species of interest …

Early stage detection of prostate cancer, one of the main causes of mortality among men, is
of great importance for better treatment of the patients. Prostate specific antigen (PSA) is a …

Early detection and diagnostics are essential for the cure of cancer which has high mortality
rate globally. In recent decades, various methods such as mammography, computed …

Sensing targeted tumor markers with high sensitivity provides vital information for the fast
diagnosis and treatment of cancer patients. A vascular endothelial growth factor (VEGF165) …